Our Team at CPHI Frankfurt 2025

Deepak Sapra
CEO, Pharmaceutical Services & Active Ingredients

Nirav Shah
Vice President, and Head, API - North Asia

Karun Gaur
Vice President and Head, Strategic Projects API

Dr. A Kalyan Chakravarthy
Executive VP & Head – SEAMEA & B2B Formulations

Kalpesh
Vice President, and Head – EU Market, API & B2B Collaborations

E Sreedhar
Executive Vice President, API Regulatory Affairs

Gustavo Mayrink De Castro Marques
Vice President and Head, API Sales & Marketing, LATAM

Dr. NM Sekhar
Vice President, API R&D

R Lalitha Kumari
Global Head of API Product Management & Head of Sales - US & Canada
About Dr.Reddy’s API Business
We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 250+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.
Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.
-
250+ APIs
-
8 Manufacturing sites
-
1970+ drug master files across global markets.
-
Over 325 ANDAs
-
Filed 4500+ patents globally, out of which 1125 have been granted.
-
Experience with complex APIs and formulations supporting early market entries.
-
Preferred pharma API supplier for pharma companies in more than 80 countries.
Sustainability
Sustainability is at the heart of our purpose. In FY2025, we served 756M+ patients, progressed to 60% carbon neutrality, and drew 68% of our power from renewables, all while staying water positive since FY2023.
We’re the only Indian pharma company to earn “A” scores in Climate Change, Water Security, and Supplier Engagement from CDP, and featured on the Dow Jones Sustainability World Index and S&P Global Sustainability Yearbook.
Our goals are clear:
- 100% renewable power by 2030
- Carbon neutrality (Scope 1 & 2) by 2030
- 1.5B patients served by 2030
We innovate with care, scale with purpose, and act with accountability to shape a healthier world.
What we achieved in the past year:
Our Achievement (awards)

25/04/2024
USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”


05/04/2024
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya


05/12/2023
Dr. Reddy's Pioneers Pharma Advancements Through Strategic Partnerships and Innovation: A Glimpse into Vision 2030: Growth Trajectory and Opportunities for Indian Pharma


04/11/2022
Dr. Reddy’s API received the excellence in API – Technical Documentation award at Aché Laboratórios Parcerias para a Excelência (Partnerships – Excellence) event!


03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021


03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021


11/11/2021
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards


19/10/2020
Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

Our Plants


About CPHI Frankfurt 2025
This flagship global event brings together 2,400+ exhibitors, 62,000+ pharma professionals, and cutting-edge innovations across APIs, biopharma, contract services, packaging, machinery, and more. It’s where the world’s pharmaceutical leaders connect to unlock new opportunities, strengthen partnerships, and stay ahead in a rapidly shifting global market.
As part of this vibrant ecosystem, we’re excited to engage with peers, customers, and collaborators. We're here to create lasting value and help you if you're exploring dependable API partnerships, looking to scale your sourcing strategies, or seeking operational agility.
Let’s meet at CPHI Frankfurt. We’re ready to support your next phase of growth with reliable, agile, and future-ready API solutions.
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.
Let’s discuss API sourcing
Join us at Hall - 9.1 | Booth - B48